<DOC>
	<DOC>NCT00860106</DOC>
	<brief_summary>The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation. The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.</brief_summary>
	<brief_title>Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation</brief_title>
	<detailed_description>DDimer levels are centralized in University Hospital of Grenoble at the end of the study</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<criteria>&gt; 18 and &lt;80 years old First or second treated proximal VTE event (+/ Pulmonary embolism) Signed informed consent Active cancer or currently treated Previous VTE&gt;2 Long term anticoagulant treatment for VTE diseases Long term anticoagulant treatment for other diseases Pregnancy, parturient or breast feeding Person deprived of freedom by judicial or administrative decision Consent unsigned</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>VTE</keyword>
	<keyword>VKA treatment</keyword>
	<keyword>VKA treatment cessation</keyword>
</DOC>